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CHAPTER 1 
cAR1 AND ITS SIGNALING PATHWAY 
Background 
Dictyostelium discoideum is a single-celled free-living social amoeba with a life cycle 
that relies on chemotaxis to find food and to survive adverse environmental conditions.  
D. discoideum is an excellent model system for studying fundamental processes in cell 
biology, such as chemotaxis, cytokinesis, phagocytosis, vesicle trafficking, cell motility, 
and signal transduction.  It is also an ideal model for genetic studies because its genome 
sequence is available, it exists as an easily transformed haploid, and it is easily imaged 
using standard microscopy techniques (Manahan 2004). 
Chemotaxis is a complex process where a cell is able to sense a chemical signal and 
migrate directionally in response to that chemoattractant gradient. Understanding 
chemotaxis in D. discoideum is important because it can be used as a model system for 
eukaryotic chemotaxis, which is implicated in many diseases.  During directed cell 
migration receptors for cyclic AMP (cAMP), a chemoattractant, have been shown to be 
uniformally distributed on the plasma membrane and G-protein activation is thought to 
mirror ligand binding (Xiao et al., 1997, Janetopoulos, 2001). Yet many of the signaling 
molecules respond in a highly amplified way, which then induce a coordinated 
remodeling of the cytoskeleton to produce cellular movement, shown in Figure 1 (Iijima 
2002, Iijima 2004, Keizer-Gunnink 2007).  This directed migration can be broken down 
into three components: gradient sensing, motility, and polarity (Devreotes 2003, 
Janetopoulos 2008).  Gradient sensing is the ability of a cell to detect an overall change 
of ligand occupancy across the periphery of a cell (Devreotes 2003). This detection then 
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leads to an internal polarized response that can result in motility. This is where a cell 
typically migrates towards higher concentrations of the chemoattractant by extending 
pseudopods or forming a leading edge in the proper direction. Polarity is the propensity 
of a cell to assume an asymmetric shape with a defined anterior and posterior, due to 
certain molecules and proteins being spatially restricted to these defined sectors 
(Janetopoulos 2003).   
 
 
 
   
Figure 1 Chemotaxing Cell: When a cell is stimulated by ligand (blue stars) binding, a number of responses occur, including actin 
polymerization (red lines), myosin formation (green lines), PI(3,4,5)P3 (lightning bolts) binding to PI3K (red hexagons), and PTEN 
(green triangles) localizing in the lagging edge.   
Directed migration is shown to be a part of D. discoideum’s developmental cycle, 
initiated by starvation.  After a few hours, cells begin to secrete cyclic AMP (cAMP). 
These propagating waves of cAMP occur every 5-6 minutes, and increase in amplitude 
over the next several hours.  They regulate the aggregation of cells into mounds.  During 
the next 12-16 hours, cells within the mound differentiate and migrate to specified 
locations in the fruiting body, including the spore sac. These spores can be dispersed to 
nutrient-rich habitats, and then germinate and resume proliferation as individual amoebae 
(Kim 1997). 
The oscillations of cAMP described above play at least two critical roles: they upregulate 
numerous genes required for the developmental phase of the D. discoideum life cycle, 
and they set up the gradients that are critical for chemotaxis during mound formation.  
The cAMP receptor 1 (cAR1) is a serpentine receptor that, along with its heterotrimeric 
alpha subunit, Gα2, are up-regulated in the first few hours after starvation and are fully 
expressed by the mound formation stage (Hereld 1994). This G-protein coupled receptor 
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(GPCR) are structurally characterized by a bundle of seven transmembrane alpha helices 
interconnected by alternating extracellular and cytoplasmic loops.  Most GPCR ligands 
are thought to bind transmembrane or extracellular receptor domains, while the G-
proteins interact with the cytoplasmic loops.  cAR1 contains four extracellular domains, 
three intracellular loops, and an intracellular C-terminal domain (Hereld 1994).  The third 
intracellular loop interacts with the heterotrimeric subunit, comprised of the Gα2 and Gβɣ 
subunits, of which the carboxyl terminus of the Gα2 subunit is the primary determinant of 
receptor coupling, seen in Figure 2.  When the chemoattractant, cAMP, binds to cAR1, it 
triggers the complete dissociation of G-protein into Gα2 and Gβɣ subunits (Elzie et al. 
2009).  cAR1 mediates the activation of Gα2 by functioning as a guanine nucleotide 
exchange factor (GEF). Thus, cAMP binds to the receptor, and conformational changes 
within the receptor internalize the response and activate further downstream signals to 
mediate actin polymerization, calcium uptake, signaling, chemotaxis, and differentiation.  
The activation of heterotrimeric G-proteins by cAR1 and the sequence of events 
following this activation are highly analogous to those also described in mammalian cells 
(Zhang 2005, Oldham 2008).  These similarities include activation of Ras, PI3K, and 
PKB.  Free Gβɣ activates Ras, a small G protein, which in turn triggers the activity of 
phosphoinositide 3-kinase (PI3K), an enzyme that converts PI(3,4)P2 to PI(3,4,5)P3.  
PI(3,4,5)P3’s can serve as a binding site for proteins with Plesktrin Homology (PH) 
domains, such as the cytosolic regulator of adenylyl cyclase (CRAC) and protein kinase 
B (Akt/PKB). The synthesis of PI(3,4,5)P3 rapidly recruits these proteins to the cell 
membrane, which in turn play a role in regulating the actin cytoskeleton.  Activation of 
cAR1 also regulates membrane association of 3-phosphoinositide phosphatase (PTEN), 
which converts PI(3,4,5)P3 to PI(3,4)P2. 
In addition to its role in signal transduction, cAR1 is uniformly distributed across the 
surface of a cell during stimulation (Hereld 1994).  The binding of the ligand, cAMP, 
during stimulation is required for phosphorylation of thirteen essential residues in the c-
terminal tail of cAR1 (Caterina 1995).  Phosphorylation of five of these residues accounts 
for two-thirds of the total phosphorylation, and that is attributed to five serine residues: 
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S299, S302, S303, S304, and S308 (Caterina 1995).  Analysis of mutants lacking 
combinations of these serines revealed that either S303 or S304 is essential for 
functionality; mutants lacking both serines are defective in all responses (Caterina 1995).  
A decrease in ligand binding is attributed to reduction in binding affinity or 
internalization of the receptors, the latter of which has not been determined to date.  
Deletion of these five residues is sufficient for a five-fold reduction in affinity of cAR1 
for cAMP (Caterina 1995).  A mutant in which all five serines in the cluster were 
substituted with alanines exhibits reduced cAMP-stimulated phosphorylation and failed 
to undergo the electrophoretic mobility shift (Caterina 1995).   
Many models have been proposed to explain the transient responses of cells to uniform 
stimulation and the prolonged responses of cells in a gradient (Devreotes and 
Janetopoulos, 2003). One model, the local excitation, global inhibition (LEGI) model, 
predicts that cAMP-occupied cAR1 sends out both an excitatory signal that activates 
downstream signaling effectors molecules and an inhibitory signal that terminates the 
response. The balance between excitation and inhibition in a gradient leads to a localized 
response. At a given concentration, the model predicts that as the fraction of the cell 
stimulated increases, the concentration of the inhibitor should also increase, leading to a 
smaller difference between excitation and inhibition, and consequently, a smaller 
response (Janetopoulos 2004).   
The removal of cAMP initiates a process of de-adaptation. Cells can respond again to 
cAMP in about 3-4 minutes (Caterina 1995).  Adaptation, a rapid reduction in agonist-
induced effector activation, has been attributed to the uncoupling of receptor from G-
protein (Caterina 1995).  This uncoupling is proposed to result from agonist-induced 
receptor phosphorylation (Caterina 1995).  In mammalian systems, the second event is 
the subsequent association of arrestin, which appears to obstruct further receptor-G-
protein interaction.  The third event in D. discoideum is an agonist-induced 
desensitization process that causes a rapid reduction in the apparent number of surface 
binding sites (Xiao 1997).  Desensitization is a series of processes that prevent 
continuous activation of the cell during prolonged exposure to agonist, thus protecting a 
cell and organism from overstimulation (Xiao 1997, Ferguson 2007, Nguyen 2011, 
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Adams 2011).  In some instances, this loss of ligand binding, often referred to as 
sequestration, has been attributed to receptor endocytosis or internalization (Caterina 
1995). Previous studies have shown that chemoattractant receptors remain uniformly 
distributed on the surface of cells that have been polarized by chemotactic gradients and 
also in cells that have been desensitized by persistent treatment with chemoattractant 
(Xiao 1997). 
 
 
 
 
 
 
Figure 2 Signaling Cascade: When the chemoattractant, cAMP, binds to cAR1, it triggers dissociation of G-protein into Gα2 and Gβɣ 
subunits.  Free Gβɣ activates Ras, a small G protein, which in turn activates phosphoinositide 3-kinase (PI3K), an enzyme that 
converts PI(3,4)P2 to PI(3,4,5)P3.  PI(3,4,5)P3’s serve as binding sites for the proteins with PH domains, such as cytosolic regulator of 
adenylyl cyclase (CRAC) and protein kinase B (Akt/PKB), and once generated, they recruit these proteins to the cell membrane.  
These proteins play a role in regulating the actin cytoskeleton.  Activation of cAR1 also regulates membrane association of 3-
phosphoinositide phosphatase (PTEN), which converts PI(3,4,5)P3 to PI(3,4)P2. 
PI3K has been implicated in the response of actin polymerization during polarity and 
chemotaxis (Korholt 2010). When levels of PI(3,4,5)P3 rise, Akt/PKBA is recruited to the 
plasma membrane, is activated and phosphorylated (Korholt 2010).  In migrating cells, 
these phosphorylation events are restricted to the cell’s leading edge (Korholt 2010).  
Thus, PKB and PI3K are essential for proper cell polarization and movement in a 
chemoattractant gradient.  Polarity, the propensity of a cell to assume an asymmetric 
shape with a defined anterior and posterior, is regulated by factors activated after the 
binding of cAMP to cAR1 (Devreotes and Janetopoulos 2003).  Even in a highly 
polarized cell, a sufficiently steep gradient applied to the side or back can break the 
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polarity and create a new front (Devreotes and Janetopoulos 2003).  To help produce an 
anterior and posterior of the cell, Pleckstrin-homology (PH) domain containing proteins, 
such as CRAC and PKB, are recruited to PI(3,4,5)P3 on the plasma membrane, thus 
localizing asymmetrically to other proteins.  When cells are placed in a gradient, these 
proteins bind to PI(3,4,5)P3, synthesized at the leading edge.  PI(3,4,5)P3 is a product of 
PI3K activation, and it’s levels are regulated by the tumor suppressor PTEN, a 
phosphoinositide 3’ specific phosphatase that dephosphorylates PI(3,4,5)P3 to PI(4,5)P2 
(Iijima 2002).  In resting cells, PTEN is localized to the plasma membrane and uniformly 
distributed around the cell.  In response to global stimulation, PTEN transiently 
dissociates from the plasma membrane with kinetics that are inversely proportional to 
those of PI3K plasma membrane association (Iijima 2002).  In a cAMP gradient, PTEN 
relocalizes to the sides and the back of the cell, and likely helps specify the rear of the 
cell.  When a gradient is moved, polarized cells will adjust their leading and lagging 
edges accordingly; polarized cells that are given a uniform stimulus of cAMP will 
respond preferentially at the leading edge. This is referred to as polarized sensitivity 
(Janetopoulos 2003). 
When cAR1 was genetically tagged with GFP, it was uniformly localized on the plasma 
membrane during chemotaxis and also following prolonged uniform stimulus (Xiao 
1997).  This data showed that cAR1 did not apparently undergo a significant 
redistribution during phosphorylation. In addition only 15-25% of the receptor was 
sequestered, with a reduced affinity for ligand (Xiao 1997).  De-adaptation appears to 
occur at the plasma membrane, thus can be detected using single molecule microscopy, 
which have provided some insight to receptor/ligand interactions. Using Cy3-cAMP, 
cAR1 binding sites were found to be uniformly distributed and diffused rapidly on the 
plane of the membrane (Hereld 1995, Ueda 2001). The on and off rates were faster at the 
front of the polarized cells. It is likely that this resulted in a higher frequency of G-protein 
association and dissociation (Ueda 2001).  Also, agonist-induced phosphorylation had no 
effect on this frequency or the distribution of the receptor (Ueda 2001).  These results 
suggest that receptor occupancy and G-protein activation parallel the external gradient 
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and there is little amplification of the gradient in these early steps (Janetopoulos 2001, 
Ueda 2001). 
Although the signaling pathway is fairly well characterized, there are many details 
missing when it comes to understanding the regulation of receptor desensitization and 
adaptation of the response, which are two critical components of gradient sensing.  Cells 
are able to sense very shallow gradients over several orders of magnitude of 
chemoattractant; it is still unclear how they manage this remarkable task. Furthermore, 
we know that the signaling cascade needs to be intact not only for motility, but for 
polarized morphology and sensitivity as well. It is of fundamental interest to determine 
the role of receptor phosphorylation in influencing these cellular events.  
Phosphorylation of the C-terminus of cAR1 is thought to provide a role in the ability of 
cells to adapt to cAMP and respond to spatial gradients that span several orders of 
magnitude. It has been demonstrated that phosphorylation of cAR1 residues 299, 302, 
303, and 304 regulate the affinity of the receptor for cAMP (Caterina 1995). I 
hypothesized that the phosphorylation status of the receptors allow them to respond to a 
wide dynamic range of cAMP concentrations and helps regulate the adaptation and de-
adaptation of cellular responses to external cAMP.  My work suggests that the 
phosphorylation state of the receptor contributes to the polarized redistribution of 
receptors and helps the cells chemotax in gradients with dramatically different mean 
concentrations. Understanding how these receptors polarize is of fundamental importance 
since they are critical for cAMP-mediated responses and the ability of a cell to sense 
concentration gradients of vastly different slopes and mean concentrations.   
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CHAPTER 2 
LOCALIZATION OF cAR1 DURING CHEMOTAXIS 
Introduction 
Chemotaxis is the physiological phenomenon of cells migrating directionally toward or 
away from chemical cues. Chemotaxis is involved in many pathological diseases in 
humans such as cancer metastasis, autoimmune diseases, and developmental defects.  
Dictyostelium discoideum is a model system for studying eukaryotic chemotaxis. D. 
discoideum cells exposed to a gradient of cAMP will move toward that source of cAMP. 
The major serpentine receptor for cAMP, cAR1, is coupled to the heterotrimeric G-
proteins α2, β, and ɣ, which activate a host of downstream effectors including PKB, 
PI3K, and Ras to regulate cell shape changes, polarity, and motility. Phosphorylation of 
cAR1 has been shown to regulate the receptor’s affinity for cAMP.  Specifically, 
phosphorylation of cAR1 at serine residues 299, 302, 303, 304, and 308 results in a 5-
fold decrease in cAMP in vitro.  Furthermore, residues 303 and 304 are the primary 
serine residues responsible for the loss of ligand binding, suggesting that phosphorylation 
of cAR1 and its subsequent decreased affinity for cAMP may be important for receptor 
sensitivity and could potentially contribute to receptor adaptation for ligand.  It is 
hypothesized that phosphorylation of cAR1 residues 299, 302, 303, and 304 regulate the 
affinity of the receptor for cAMP, and thus allow the cell to be able respond to a wide 
dynamic range of cAMP concentrations, which regulates adaptation and de-adaptation of 
cellular responses to external cAMP.  It is expected that chemotaxis will be significantly 
decreased in the mutants compared to wildtype cells.   
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Methods 
Media and buffers: 
HL-5 was purchased from Formedium.  HL-5 media consists of 22 grams of HL-5 
powder, 10 grams of dextrose and 1 Liter of double distilled H2O.  Developmental Buffer 
(DB) consists of 5mM Na2HPO4, 5mM KH2PO4, 1mM CaCl2, and 2mM MgCl2.   
Strains used: 
Dictyostelium discoideum wild type strain expressing cAR1-GFP and mutants expressing 
cAR1-GFP A4 (S299A, S302A, S303A, S304A) or cAR1-GFP E4 (S299E, S302E, 
S303E, S304E) were used for cAMP chemotaxis.  These mutants were expressed in a 
wildtype AX2 background, as well as a cAR1-/3- background.  These strains confer 
G418 resistance.   
The original strains were obtained from the Devreotes laboratory at Johns Hopkins, 
including cAR1/3.1 and cAR1/3.2.  cAR1.1 is the A4, E4, and WT in car1/3.1 
background.  The cAR1 gene contains a BgII insertion.  cAR1.2 is the A4, E4, and WT in 
car1/3.1 background. The cAR1 gene does not contain BgII insertion.  cAR1.3 is the E4 
and WT in car1/3.2 background. The cAR1 gene does not contain BgII insertion.   
*It is to be noted that cAR1.3-A4-GFP cells were never achieved in rounds of transformations when 
deleting the BglII site mutation.  This is presumably due to the interaction of the BglII site mutation and the 
A4 mutations in the c-terminal tail.  The wildtype cAR1-GFP was transformed into cAR1.1, AX2 (wildtype 
background), and cAR1.3.   
cAMP preparation: 
10mM stock of cAMP (Sigma) solution was made in double distilled H2O.  For cAMP 
development a 2.5 M working solution was made in DB buffer.  For cAMP chemotaxis, 
a 100 nM, 10 M, and 10 mM working solution was made in DB buffer. 
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cAMP development: 
50 mL of 2x10
6
 cells per ml were centrifuged at 1400 rpm and subsequently washed 
twice times with DB buffer.  The pellet was resuspended in 5 mLs of DB buffer resulting 
in 2 x 10
7
 cells per mL.   The 5 mL resuspension was transferred to a 150 mL flask and 
was shaken at 110 rpms for 1hr.  After the initial 1hr shake, the cells were pulsed with 
approximately 100 L of the 2.5 M cAMP every 6 minutes for 5 hrs.  After the 6hr 
development, the cells were treated with 5mM caffeine (only for biochemical studies) 
and shaken for 30 minutes to basalate the cells or the cells were immediately used for 
assays.   
Imaging:  
All images were acquired on a Marianis Workstation equipped with a Cool Snap CCD 
camera and an Extended QE, high-speed cooled CCD camera (Cascade 512 II).   The 
microscope used was an inverted, wide-field epifluorescence microscope (Zeiss Axio 
Observer Z1).  Images were acquired by SlideBook software (Intelligent Imaging 
Innovations).   
Cell tracking: 
In order to visualize the migration of cells and record the specifics of chemotactic 
response; a program was written with LabVIEW™ software.  Time-lapse image data 
from Slidebook was exported to .avi movie format.  The movie files were loaded in the 
cell-tracking program.  The user can view the image data in a window, play the file or 
examine individual frames.  Tracking of cells uses the machine vision algorithms from 
LabVIEW™ Vision Development Package.  The user selects the cell to track with a 
mouse, and the software records the x,y pixel coordinates of the centroid of intensity in 
the image for the fluorescent cell. Once the x,y path of the cell is known and the source of 
the chemoattractant is identified the chemotactic response can be quantified.  The 
measured responses are the velocity of travel, the direction of travel (chemotactic index), 
and the persistence.  The velocity is simply the distance between x,y pairs of the cell path 
divided by the time between points. Velocity can be measured point-to-point or 
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integrated over several time steps. Chemotactic index (CI) is the cosine of the angle 
formed by the travel vector and the vector from the cell to the source.  The travel vector 
is determined by the x,y track of the cell. The travel vector can be taken at each frame 
increment or integrated over several frames where CI (n) = cos (angle S Xn Xn+m). CI is 
the chemotactic index of the cell at time n, S is the point source of the chemoattractant, 
Xn is cell’s position at the start point of the travel vector, and Xn+m is the cell’s position at 
the end point of the travel vector after the integration time increment m. It is useful to 
calculate the velocity and chemotactic index over short time scales corresponding to the 
movement of one cell length. For these time scales the chemotactic persistence, defined 
as the length of cell travel path divided by the change in distance to the source, is equal to 
the chemotactic index.  The calculation of persistence is more useful over long time 
scales. 
Gene Expression Assay 
After treatment of caffeine, developed cells were centrifuged for 5 minutes at 500 x g at 
4
o
C, and the supernatant was removed.  This was done twice with 30mL of ice cold DB 
buffer.  The cells were resuspended at 2 x 10
7
 cells/mL in DB and kept on ice.  0.5-mL of 
competent cells on ice at a density of 2 × 10
7
 cells/mL were transferred to a 5-mL flask 
shaking at 110 rpm.  Within 2 minutes, 100 uM of cAMP were added to a final 
concentration of 1uM.  A Western Blot was performed.  This was done by transferring 
50uL of cells to microcentrifuge tubes containing 17 uL of 4 × SDS sample buffer and 
heated at 95°C for 5 minutes.  Wells were loaded in precast gels with 2.5 uL of sample (4 
× 10
4
 cells).  Gels were run at 200 V for 90 minutes.  Proteins were transferred to a 
nitrocellulose membrane at 30 V for 90 minutes.  After the transfer, the nitrocellulose 
membrane was rinsed with TBS twice.  The membrane was incubated in 10 mL of 
blocking buffer for 1 hour at room temperature while shaking.  The blocking buffer was 
discarded and the membrane was rinsed with TBS twice.  The membrane was incubated 
with a primary antibody 1:1000 at 4°C overnight.   The primary antibody was removed, 
and the membrane was rinsed with TBS twice, and further washed with TBST for 10 
min, thrice at room temperature.   The membrane was incubated with IR dye 680 
conjugated secondary antibody (Li-Cor) 1:10,000 for 1 hour at room temperature. The 
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secondary antibody was removed, and the membrane was rinsed with TBST thrice at 
room temperature.  It was washed quickly with TBS twice and scanned in the Odyssey IR 
dye detection system.  PKB substrate phosphorylation assays were also performed in the 
same way using a PKB substrate phosphorylation specific primary antibody. 
PCR Mutagenesis 
PCR (Polymerase chain reaction) was performed using Pfu polymerase, 10 mM dNTP, 
template, and primers.  The PCR was performed for 15 cycles, with a 10 minute 
extension time.  After PCR, the product was restriction digested for three hours at 37
o
C.  
The DNA was precipitated and ligated at 18
o
C overnight.  A bacterial transformation was 
performed using competent cells.  The cells were thawed on ice, mixed with the ligated 
DNA, and heat shocked at 42
o
C for one minute.  After allowing 1 hour for growth during 
shaking at 37
o
C, the cells were plated on an LB/Ampicillin plate.  Colonies were picked 
from each plate, grown overnight at 37
o
C, and precipitation for isolation of the finished 
plasmid.  This was performed multiple times to obtain a ДBglII construct for WT, A4, 
and E4.  This plasmid was transformed into fresh D. discoideum cells.  
DB agar/SM plates 
Cells were developed as discussed above.  These cells were plated on 1.5% agarose at 1:1 
and 1:10 ratio to detect aggregation defects.  In short, 1mL of cells were plated, the cells 
were allowed to settle and adhere to the agar for 10 minutes, and the liquid was 
subsequently removed.  
Latrunculin A treatment 
During chemotaxis assays, cells were treated with Latrunculin A to prevent actin 
polymerization.  The cells were suspended in 1.8 mL of DB buffer in a chamber slide.  1 
uL of Latrunculin A was added to 199 uL of DB buffer, final concentration of 50 uM.  
This was added to the chamber slide during chemotaxis to achieve a final concentration 
of 5 uM drug treatment.   
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Subcloning 
PCR subcloning was performed using Pfu polymerase, 10 mM dNTP, template, and both 
a forward and reverse primer.  The PCR was performed for 35 cycles, with a 10 minute 
extension time.  The PCR products were run out using gel electrophoresis.  The bands 
were excised and digested using the Qiagen Gel Extraction Kit.   After PCR, the product 
was restriction digested for overnight at 37
o
C.  The DNA samples were run out using gel 
electrophoresis, and the bands excised and isolated.  The DNA was ligated at 18
o
C 
overnight.  A bacterial transformation was performed using competent cells.  The cells 
were thawed on ice, mixed with the ligated DNA, and heat shocked at 42
o
C for one 
minute.  After allowing 1 hour for growth during shaking at 37
o
C, the cells were plated 
on an LB/Ampicillin plate.  Colonies were picked from each plate, grown overnight at 
37
o
C, and precipitation of the finished plasmid.  This plasmid was transformed into fresh 
D. discoideum cells.   
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Results 
Chemotaxis, Localization, and Latrunculin Treatment Round 1 
The experiments presented here have been designed to characterize the cAR1:A4 and 
cAR1:E4 mutations and their effect on the cell’s physiology.  In the first cAR1/3- double 
null background, denoted as “cAR1.1.”,   the phospho-mimic, E4, has a chemotactic 
defect at high (10 mM) and low (100 nM) cAMP concentrations.  Looking solely at 
chemotactic index, the cAR1.1:E4 cells travel towards the needle at 37% efficiency at 
100 nM, 82% efficiency at 10 uM, and 77% efficiency at 10 mM.  In the cAR1.1 
knockout, the phospho-null, A4, has a chemotactic defect at all concentrations, with only 
about a 13% chemotactic efficiency at high and low concentrations, and 35% efficiency 
at 10 uM.  Wild type cAR1-GFP expressed in cAR1.1 cells chemotax at approximately 
89% efficiency at all concentrations.  The speed of all of the mutants is comparable to 
wild type cells at about 7-10 microns/per minute.  These results are seen in Figure 3, in 
graph form and in Table 1, a quantitative view.  When treated with Latrunculin A, the 
cAR1.1:E4:PH-RFP cells respond to uniform cAMP stimulation; thus, the PH-RFP 
translocated to the plasma membrane, however, a crescent is not formed in the direction 
of the micropipette.  Also, there is very little redistribution of the receptor with 
Latrunculin treatment.  The cAR1.1:A4:PH-RFP cells do not respond to uniform 
stimulation, and a translocation event is not seen.  cAR1.1:A4 cells expressing GFP 
tagged mutant receptors were treated with Latrunculin A. The A4-receptors redistributed 
to the entire cell, including the cytosolic compartments (data not shown).  In very 
preliminary studies, cAR1.1:E4 cells treated with Latrunculin A do not appear to 
redistribute the E4 receptorSs; even in the absence of an actin cytoskeleton, intensity in 
the former lagging edge remains, with receptors in vesicles.  All data was performed in 
the absence of caffeine, and confirmed.   
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Figure 3 (A, B, C): Chemotaxis in cAR1.1 mutants with BglII site: All data was performed in the absence of caffeine, and confirmed.  
The concentration noted (100 nM, 10 uM, and 10 mM) is the concentration of cAMP in the needle during the assay.  Persistence, 
speed, and index are defined in the Methods section.   
The cAR1.1:A4-GFP and cAR1.1:E4-GFP, displayed a differential localization when 
imaged in polarized cells in a gradient (Figure 4).  cAR1.1:E4, which is a phospho-mimic 
and should act as a desensitized receptor was found on the sides and lagging edge of the 
cell.  cAR1.1:A4, should act as a phospho-null and be predicted to be a hyper-sensitive 
receptor, was found in the newly formed pseudopodia of a motile cell. This particular 
construct has given us problems, and these results need to be repeated again. We are 
hoping to get this construct without the BglII insertion to again test the distribution of the 
phosphonull receptor in migrating cells. Also, in a uniform stimulus, the mutant cells still 
maintained their differential localization (data not shown).   
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Figure 4: cAR1.1-GFP A4, cAR1.1-GFP E4, and cAR1.1-GFP WT Localization shown here uninduced.   
Next, I decided to look at the time course of cellular events in response to a uniform 
stimulus of cAMP in the wildtype and mutant receptors. PKB substrate phosphorylation 
can be measure by Western blot analysis and is found downstream of major effectors, 
including heterotrimeric G-proteins, Ras, PI3K, and PIP3.  Using PKB substrate 
phosphorylation, the signaling pathway is seen to be functioning, albeit at different 
intensities (Figure 5).  The WT cells were not tested due to growth issues; however, it is 
postulated that they will saturate at high concentrations, similar to E4 cells.  The E4 cells 
show a higher basal PKB phosphorylation level than A4, and seem to saturate at a higher 
concentration of 100 uM.  The A4 cells terminate their response quicker at higher 
concentrations (above 10 uM), because they seem to saturate at much lower 
concentrations, and the response decreases with increasing concentrations of cAMP.  
This would lead us to test other downstream outputs and also use a time course to see if 
the kinetics are different for the mutants, compared to wildtype.  Both of these mutants 
activate PKB, thus demonstrating that the signaling pathway regulating Ras activation, 
PI3K, and PI(3,4,5)P3 signaling are functional.   
 
 
 
 
A4
4 
E4
4 
WT
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Figure 5: PKB Substrate Phosphorylation: The lanes are as follows: 1: Ladder, 2: Uninduced, 3: 10uM cAMP (no caffeine), 4: 20uM 
cAMP, 5: 40uM cAMP, 6: 60uM cAMP, 7: 100uM cAMP, 8: Uninduced, 9: 10uM cAMP (no caffeine), 10: 20uM cAMP, 11: 40uM 
cAMP, 12: 60uM cAMP, 13: 100uM cAMP; this is the same for both gels.   
Chemotaxis Round 2: All mutations of cAR1 expressed in cAR1/3.1 and designated as 
the cAR1.2 cell line 
In the second cAR1/3- set of experiments, we used cells denoted as “cAR1.2.” The 
phospho-mimic, E4, was not tested due to mutagenesis issues.  First, cells were tested for 
expression of the cAR1-GFP plasmid.  These results are seen in Figure 6.   
 
Figure 6: Gene Expression Assay: The lanes are as follows: 8: Positive Control, 9: Positive Control 2, 10: Blank, 11: cAR1.2-WT-
GFP (30s), 12: cAR1.2-WT-GFP (60s), 13: cAR1.2-WT-GFP (90s), 14: cAR1.2-WT-GFP (120s), 15: cAR1.2-WT-GFP (uninduced). 
The WT-cAR1.2-GFP showed very good chemotaxis efficiency >90% at both 
concentrations.  The speed is comparative to wildtype (AX2) cells (approximately 10 
microns/sec).  The persistence is also comparable to wildtype cells at approximately 54-
62%.  These results show that the WT cAR1 fused to GFP is fully functional and rescues 
the cAR1.2 nulls.   
A4:   1   2   3   4   5   6   7   8   9   10 11 12 13  E4  1   2   3   4  5   6   7  8  9  10 11 12 13 
      8      9    10    11   12    13    14  15 
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The WT-cAR1.2-GFP construct expressed in a wildtype background, however, shows a 
chemotactic deficiency at 10 mM, where the index and persistence remains comparable 
to wildtype, but the speed is deficient.  At 10 uM, the cells chemotax at an efficiency of 
96%, 65% persistence, and 10 microns/sec.  At 10 mM, the cells chemotax at 89% 
efficiency, 61% persistence, and 7 microns/sec.  The reason for that deficiency could be 
that there are too many receptors due to the overexpression of the cAR1 gene.  
Developmental delays have been reported before when cAR1 is overexpressed, as is the 
case here.  
The A4-cAR1.2-GFP construct showed very good chemotaxis efficiency >85% at all 
concentrations.  The speed is comparative to wildtype (AX2), if not better than wildtype, 
at approximately 10.4-12.8 microns/sec.  The persistence is slightly lower than wildtype 
as the persistence decreases as concentrations increase.  The speed shows a similar profile 
of decreasing as concentration increases, though the variability is smaller.  These results 
show a full rescue of cAR1 in the presence of cAMP.   
The A4-cAR1.2-GFP- expressed in a wildtype background shows a chemotactic 
deficiency at 10 uM, where the index and persistence remains comparable to wildtype, 
but the speed is deficient, showing approximately 9 microns/sec.  At 10 uM, the cells 
chemotax at impeccable efficiency of 96%, 60% persistence, and 9 microns/sec.  At 10 
mM, the cells chemotax at 89% efficiency, 62% persistence, and 11.6 microns/sec.  The 
reason for the deficiency at lower concentration could be a saturation of receptor due to 
the overexpression of cAR1.  Also, the two AX2 cell lines show a very similar profile, 
with high efficiency, persistence, and comparative speed, just as the cAR1.2 nulls show a 
similar profile.  All of these results are seen in Figure 7 and Table 2 .   
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Figure 7: Chemotaxis without BglII site in cAR1.2: Both wildtype cAR1.3-GFP receptors and cAR1.3-A4-GFP were assayed for 
chemotactic parameters.  Persistence, index and speed are defined in the Methods section.   
Table 2: Chemotactic Parameters II 
Cell cAMP 
Concentration 
Persistence Index Speed 
cAR1.2-WT-GFP 10uM 0.545352 0.940805 10.2456 
 10mM 0.620904 0.905291 9.58083 
A4AX2 10uM 0.602392 0.963527 8.996255 
 10mM 0.627433 0.898536 11.61405 
cAR1.2-A4-GFP 100nM 0.517856 0.887494 12.7976 
 10uM 0.446887 0.905853 12.26774 
 10mM 0.435033 0.847362 10.44162 
WTAX2 10uM 0.659481 0.962839 10.08964 
 10mM 0.616906 0.896767 7.148719 
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Chemotaxis, Localization and Latrunculin Treatment Round 3: All constructs expressed 
in new cAR1/3- double null designated “cAR1.3”  
The WT-cAR1.3-GFP cells were tested for chemotactic efficiency and in other 
experiments, the role of the cytoskeleton in redistributing the receptors was tested by 
inhibiting the actin cytoskeleton using Latrunculin drug treatment.  The cells chemotax at 
a high efficiency (see Figure 8), and when treated with Latrunculin, the cells rounded up 
and the receptor did not redistribute.  Also, the receptor in these cells is distributed 
uniformly, with a subtle difference in intensity in the back of the cells.  The star is the 
location of the needle. 
 
Figure 8: WT-cAR1.3-GFP Cells During Chemotaxis: The images reflect the cells’ positions at 30s, 180s, 600s, and 900s.   
The E4-cAR1.3-GFP cells were tested for chemotactic efficiency.  The cells chemotax at 
a high efficiency, and when treated with Latrunculin, the cells rounded up and the 
receptor did not redistribute.  Also, the receptor in these cells shows a localization of 
intensity in the back of the cells, with a gradient up the sides of the very elongated cells, 
seen in Figure 9.   
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Figure 9: E4-cAR1.3-GFP Localization during Chemotaxis taken at 1200 seconds.   
DB Agar and SM Bacterial Plates 
The DB Agar plates were used to show the ability of the different receptors to rescue 
development and aggregation.  All cell lines were tested, and the results reported in 
Figure 10.   
 
Figure 10: DB Agar Plates: They are listed as follows: A: E4-cAR1.3-GFP, B: WT-cAR1.3-GFP, C: cAR1.3, D: WT-cAR1.3-GFP in 
extrachromosomal vector pdm304, E: WT-cAR1-GFP-AX2 in extrachromosomal vector pdm304, F: WT-cAR1-GFP-AX2, G: A4-
cAR1-GFP-AX2.   
  
A B C D E 
F G 
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Discussion 
The phosphorylation of the receptors has been shown to elicit downstream responses, and 
S299, S301, S303 and S304 have been shown to be important in eliciting these responses.  
To further characterize this phosphorylation, these serine residues were mutated to 
alanines and glutamic acid.  Alanine was used because of its lack of ability to react with 
phosphate.  Glutamic acid was used because it has oxygen in the phosphate position, and 
thus cannot be phosphorylated upon cAMP binding to the receptor.  Figure 6 shows the 
expression of all mutants in the cAR1.3 backgrounds.  Also, DB agar plates were made at 
different cell concentrations to test for developmental defects in the mutants.  These 
plates showed the rescue of all cell lines, thus demonstrating the ability of the mutant 
receptors to function.  The cAR1.3 (cAR1/3 knockout) was fully rescued by both E4 and 
WT.  The AX2 cells with both WT and A4 showed an overexpression profile seen in 
cAR1 wildtype receptor overexpression (Kim 1997).   
Cells use chemotaxis to migrate up chemical gradients. As the cells move towards the 
chemoattractant source, receptors are phosphorylated and may be dynamically 
exchanged. Our data shows that there is a redistribution of the receptors to the rear of the 
cell.  It is possible that a phosphatase is at work in the rear of the cell and 
unphosphoryated receptors migrate to the leading edge.  This mechanism may take 
advantage of the highly polarized nature of a cell.  Polarity involves an asymmetric 
alignment of important proteins in the cell, such as PTEN and PI3K, found in the lagging 
and leading edge, respectively which alter the concentration of various phosphoinositides 
at the front and rear as well.  It is possible that unphophorylated and phosphorylated 
receptors associate within specific phosphoinositide domains. The phosphorylation state 
may be critical as WT cells have both sensitive (unphosphorylated) and desensitized 
(phosphorylated) receptors and can respond directionally to a wide range of cAMP.  I 
speculate that these sensitive and desensitized receptors are turned over and recycled 
dynamically, as the cell continues to move up a gradient.   
The mutants have differences in both sensitivity and localization.  The cAR1-A4-GFP 
cells are unable to phosphorylate at the four mutated residues and are therefore more 
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sensitive to the gradient.  All of the receptors appear to localize to the front of the cell, in 
the newly formed pseudopodia, as they try to sense the gradient and chemotax towards 
the needle.  The cAR1-E4-GFP cells have a higher level of chemotactic response than 
cAR1-A4-GFP.  They are desensitized and the receptors localize as an internal gradient 
towards the lagging edge of the cell.  The receptors in the cAR1-WT-GFP cells are 
uniformly distributed on the plasma membrane.   
In terms of downstream signaling, the PKB substrate phosphorylation is a great output to 
use to determine activation of the signaling pathways.  The cAR1-WT-GFP cells are 
expected to be able to activate downstream responses at both high and low concentrations 
of cAMP, and thus would saturate only at very high concentrations.  The cAR1-E4-GFP 
cells saturate at 100 uM, which is very high, as they need higher levels of cAMP to 
promote downstream signaling.  The A4 cells saturate at 10 uM, a 10-fold decrease in 
concentration, because they are overly sensitive to the concentration and need less cAMP 
to propagate downstream signaling.   
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CHAPTER 3 
CONCLUSIONS 
The mutations made in the C-terminus of cAR1 have led to a difference in sensitivity and 
in localization during chemotaxis to cAMP.  This was tested in various ways including 
the examination of signaling pathways in a gradient of chemoattractant, the differential 
localization, and the saturation of PKB substrate phosphorylation in cells expressing 
wildtype and mutant receptors.   
A future step in this project is to see if the mutants correlate with internalization of the 
receptor and also electromobility shift to look at the phosphorylation state of the receptor.  
The main question I set out to answer was how phosphorylation affected sensitivity and 
adaptation of the receptor to differing concentrations of chemoattractant, but then we 
made this remarkable discovery that the receptors also seem to redistribute when in a 
cAMP gradient. When taking into account sensitivity, a loss in ligand binding would also 
be expected.  The A4 cells need less ligand to get response, but they can’t detect the 
gradient, so even in a saturating concentration, they will not phosphorylate, and remain 
sensitive.  The E4 cells are desensitized, which means they need more ligand to elicit a 
response.  These receptors redistribute strongly to the rear, which suggests there is a 
mechanism that sends phosphorylated receptors rearward.  They use an asymmetric 
distribution and redistribution of receptors to attempt to gain sensitivity across the whole 
cell.   Wildtype receptors also partially relocalize to the rear during chemotax since there 
are a higher fraction of receptors that are phosphorylated.  They respond at all 
concentrations of cAMP tested.   
A critical aspect of this relocalization is that this differential response, if it also occurs in 
wildtype receptors, would help sharpen the internal responses and help explain the highly 
localized responses seen in migrating cells.  Future directions would include genetically 
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tagging cm1234, where all serine residues are mutated to alanine and glycine (cAR1/2/3) 
or deleted (cAR4), and looking for differences when all basal phosphorylation is 
prevented.  This would also highlight the importance of the S299, S301, S302, and S304 
residues used in this work.   
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